301 related articles for article (PubMed ID: 37534829)
1. Harnessing neutrophil plasticity for HCC immunotherapy.
Ramon-Gil E; Geh D; Leslie J
Essays Biochem; 2023 Sep; 67(6):941-955. PubMed ID: 37534829
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment.
Wang L; Liu Y; Dai Y; Tang X; Yin T; Wang C; Wang T; Dong L; Shi M; Qin J; Xue M; Cao Y; Liu J; Liu P; Huang J; Wen C; Zhang J; Xu Z; Bai F; Deng X; Peng C; Chen H; Jiang L; Chen S; Shen B
Gut; 2023 May; 72(5):958-971. PubMed ID: 35688610
[TBL] [Abstract][Full Text] [Related]
3. Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil.
Peng H; Wu X; Liu S; He M; Tang C; Wen Y; Xie C; Zhong R; Li C; Xiong S; Liu J; Zheng H; He J; Lu X; Liang W
Clin Transl Med; 2023 Jul; 13(7):e1340. PubMed ID: 37491740
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
[TBL] [Abstract][Full Text] [Related]
5. Neutrophils as potential therapeutic targets in hepatocellular carcinoma.
Geh D; Leslie J; Rumney R; Reeves HL; Bird TG; Mann DA
Nat Rev Gastroenterol Hepatol; 2022 Apr; 19(4):257-273. PubMed ID: 35022608
[TBL] [Abstract][Full Text] [Related]
6. Neutrophils: Driving inflammation during the development of hepatocellular carcinoma.
Chen H; Zhou XH; Li JR; Zheng TH; Yao FB; Gao B; Xue TC
Cancer Lett; 2021 Dec; 522():22-31. PubMed ID: 34517084
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil diversity and plasticity in tumour progression and therapy.
Jaillon S; Ponzetta A; Di Mitri D; Santoni A; Bonecchi R; Mantovani A
Nat Rev Cancer; 2020 Sep; 20(9):485-503. PubMed ID: 32694624
[TBL] [Abstract][Full Text] [Related]
8. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy.
Liu Y; Xun Z; Ma K; Liang S; Li X; Zhou S; Sun L; Liu Y; Du Y; Guo X; Cui T; Zhou H; Wang J; Yin D; Song R; Zhang S; Cai W; Meng F; Guo H; Zhang B; Yang D; Bao R; Hu Q; Wang J; Ye Y; Liu L
J Hepatol; 2023 Apr; 78(4):770-782. PubMed ID: 36708811
[TBL] [Abstract][Full Text] [Related]
9. Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.
Liu M; Zhou J; Liu X; Feng Y; Yang W; Wu F; Cheung OK; Sun H; Zeng X; Tang W; Mok MTS; Wong J; Yeung PC; Lai PBS; Chen Z; Jin H; Chen J; Chan SL; Chan AWH; To KF; Sung JJY; Chen M; Cheng AS
Gut; 2020 Feb; 69(2):365-379. PubMed ID: 31076403
[TBL] [Abstract][Full Text] [Related]
10. Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization.
Xu W; Weng J; Xu M; Zhou Q; Liu S; Hu Z; Ren N; Zhou C; Shen Y
Cancer Immunol Immunother; 2024 Feb; 73(3):56. PubMed ID: 38367070
[TBL] [Abstract][Full Text] [Related]
11. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
12. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity.
Xue R; Zhang Q; Cao Q; Kong R; Xiang X; Liu H; Feng M; Wang F; Cheng J; Li Z; Zhan Q; Deng M; Zhu J; Zhang Z; Zhang N
Nature; 2022 Dec; 612(7938):141-147. PubMed ID: 36352227
[TBL] [Abstract][Full Text] [Related]
13. The immunosuppressive tumor microenvironment in hepatocellular carcinoma-current situation and outlook.
Zhou Z; Hu Y; Wu Y; Qi Q; Wang J; Chen L; Wang F
Mol Immunol; 2022 Nov; 151():218-230. PubMed ID: 36179604
[TBL] [Abstract][Full Text] [Related]
14. CXCR2 inhibition enables NASH-HCC immunotherapy.
Leslie J; Mackey JBG; Jamieson T; Ramon-Gil E; Drake TM; Fercoq F; Clark W; Gilroy K; Hedley A; Nixon C; Luli S; Laszczewska M; Pinyol R; Esteban-Fabró R; Willoughby CE; Haber PK; Andreu-Oller C; Rahbari M; Fan C; Pfister D; Raman S; Wilson N; Müller M; Collins A; Geh D; Fuller A; McDonald D; Hulme G; Filby A; Cortes-Lavaud X; Mohamed NE; Ford CA; Raffo Iraolagoitia XL; McFarlane AJ; McCain MV; Ridgway RA; Roberts EW; Barry ST; Graham GJ; Heikenwälder M; Reeves HL; Llovet JM; Carlin LM; Bird TG; Sansom OJ; Mann DA
Gut; 2022 Apr; 71(10):2093-106. PubMed ID: 35477863
[TBL] [Abstract][Full Text] [Related]
15. A Positive Feedback Loop Between Cancer Stem-Like Cells and Tumor-Associated Neutrophils Controls Hepatocellular Carcinoma Progression.
Zhou SL; Yin D; Hu ZQ; Luo CB; Zhou ZJ; Xin HY; Yang XR; Shi YH; Wang Z; Huang XW; Cao Y; Fan J; Zhou J
Hepatology; 2019 Oct; 70(4):1214-1230. PubMed ID: 30933361
[TBL] [Abstract][Full Text] [Related]
16. Tumour-associated neutrophils: Potential therapeutic targets in pancreatic cancer immunotherapy.
Wu Q; Mao H; Jiang Z; Tang D
Immunology; 2024 Jul; 172(3):343-361. PubMed ID: 38402904
[TBL] [Abstract][Full Text] [Related]
17. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma.
Fu Y; Liu S; Zeng S; Shen H
J Exp Clin Cancer Res; 2019 Sep; 38(1):396. PubMed ID: 31500650
[TBL] [Abstract][Full Text] [Related]
18. Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review.
Li B; Yan C; Zhu J; Chen X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Jiang W; Fang W
Front Immunol; 2020; 11():1037. PubMed ID: 32547550
[TBL] [Abstract][Full Text] [Related]
19. Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma.
Xiong Z; Chan SL; Zhou J; Vong JSL; Kwong TT; Zeng X; Wu H; Cao J; Tu Y; Feng Y; Yang W; Wong PP; Si-Tou WW; Liu X; Wang J; Tang W; Liang Z; Lu J; Li KM; Low JT; Chan MW; Leung HHW; Chan AWH; To KF; Yip KY; Lo YMD; Sung JJ; Cheng AS
Gut; 2023 Sep; 72(9):1758-1773. PubMed ID: 37019619
[TBL] [Abstract][Full Text] [Related]
20. Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.
Akkız H
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
